Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac On a Roll

publication date: Dec 14, 2007

The news flow from Sinovac Biotech Ltd. was very positive this week. Healive™, a hepatitis A vaccine, was chosen by the Beijing Medicine Bidding Center as one of two inactivated hepatitis A vaccines in pre-filled syringes for its hepatitis A vaccination program. A few days earlier, Sinovac’s Q3 financial report showed the fortunes of Sinovac to be very much on the upswing. Total sales jumped 141% year-over-year and net income climbed to $2.2 million, a 23-fold jump from the $93,000 recorded in 2006. More details...

Stock Symbols: (AMEX: SVA) (NYSE: GSK)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital